GCP
PLSE icon

GSA Capital Partners’s Pulse Biosciences PLSE Stock Holding History

GSA Capital Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,916
Closed -$176K – 2059
2025
Q1 		$176K Buy
+10,916
New +$203K 0.02% 1420
2024
Q2 		– Sell
-33,018
Closed -$288K – 1947
2024
Q1 		$288K Buy
+33,018
New +$303K 0.02% 1239
2022
Q1 		– Sell
-11,102
Closed -$164K – 1733
2021
Q4 		$164K Buy
+11,102
New +$221K 0.02% 1255
2018
Q4 		– Sell
-12,000
Closed -$170K – 1661
2018
Q3 		$170K Buy
+12,000
New +$170K 0.01% 1510

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

GSA Capital Partners's PLSE Position: Q2 2025 in Review

GSA Capital Partners sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 10,916 shares — an estimated $176K sold.

GSA Capital Partners first reported a position in PLSE in Q3 2018 and held it in 4 quarters. The position peaked at $288K in Q1 2024. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

  • GSA Capital Partners reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 10,916 Pulse Biosciences shares in Q2 2025, an estimated $176K.
  • GSA Capital Partners first reported a position in Pulse Biosciences in Q3 2018 and held it in 4 quarters.
  • GSA Capital Partners's Pulse Biosciences position peaked at $288K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.